tel: +420 602 338 783
The United States is, according to a recent declaration from President Joe Biden, aiming to offer all US adults vaccination against SARS-CoV-2, the virus that causes COVID-19, by May 2021.1 To date, furthermore, more than 30 people per 100 across the country have received at least 1 dose of a currently approved vaccine.2 The vaccination
Medical organizations and dialysis companies are commending the Biden administration’s March 25 announcement of a partnership with outpatient dialysis clinics to provide COVID-19 vaccinations to patients receiving in-center dialysis. “Through this partnership, the Administration will provide vaccines directly to dialysis treatment centers so patients who typically go three times a week for treatment are able
Currently, the development of vaccines for influenza and other viruses typically relies on egg-based manufacturing. This approach, and the newer technique of vaccine production in cell cultures, carry the risk of mutations that may reduce the efficacy and immunogenicity of the vaccines. Additionally, there are ongoing needs for greater production speed and capacity to enable
Commentaires récents